Tafamidis Should Be Accessible for All Patients With Transthyretin Amyloid Cardiomyopathy∗

Publication date: Available online 6 January 2021Source: JACC: Heart FailureAuthor(s): Mitchell A. Psotka
Source: JACC: Heart Failure - Category: Cardiology Source Type: research